NCT04169659

Brief Summary

The aim of the trial is to study efficacy and safety of Kyphoplasty technique with porous titanium microspheres in patients with type A vertebral body fracture (according to Magerl classification).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 20, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2020

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2020

Completed
Last Updated

November 20, 2019

Status Verified

November 1, 2019

Enrollment Period

1.6 years

First QC Date

July 6, 2019

Last Update Submit

November 16, 2019

Conditions

Keywords

KyphoplastyEBMTitaniumMicrosphereVertebral fracture

Outcome Measures

Primary Outcomes (1)

  • Feasibility of prototype device usage, as assessed by Change from baseline in post-surgical complication rate at 1 month.

    Demonstrate if the prototype device is useful.

    1 month post operative control

Secondary Outcomes (4)

  • Visual analogical Scale (VAS) and changing in time.

    immediate, follow-up at 1-3-6 months after trauma

  • Pre, Post operation Vertebra height and changing in time

    immediate, follow-up at 1-3-6 months after trauma

  • Acquired kyphosis

    6 months after trauma

  • Ostheogenesis

    6 months after trauma

Study Arms (2)

Kyphoplasty with Titanium spheres

EXPERIMENTAL

Patients treated with kyphoplasty with baloons and insertion of titanium microspheres inside the body vertebra.

Device: Kyphoplasty with insertion of Sctructured Titanium Microspheres

Kyphoplasty with Polymethylmethacrilate

ACTIVE COMPARATOR

Patients treated with Kyphoplasty with baloons and insertion of Polymethylmetacrylate inside the body vertebra.

Device: Kyphoplasty with Polimethylmetacrilate (convetional surgery)

Interventions

Under fluoroscophy, we introduce a transpeduncolar trocar inside the vertebral body where is performed a kyphoplasty with insertion of baloons. When the dome is cretated we introduce structured titanium microspheres until the dome is full of material.

Kyphoplasty with Titanium spheres

Under fluoroscophy, we introduce a transpeduncolar trocar inside the vertebral body where is performed a kyphoplasty with insertion of baloons. When the dome is cretated we introduce Polimethylmetacrilate until the dome is full of material.

Kyphoplasty with Polymethylmethacrilate

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Magerl Type A Thoracolumbar fracture with no neurological deficits
  • Age\>18yy and \< 80yy
  • No ligament lesions

You may not qualify if:

  • age \< 18yy or \> 80yy
  • Ligament lesions
  • refusal to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriele Costantino

Palermo, PA, 90100, Italy

RECRUITING

MeSH Terms

Conditions

Spinal Fractures

Interventions

Kyphoplasty

Condition Hierarchy (Ancestors)

Spinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

VertebroplastyCementoplastyOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Model Details: Prospective Rondomized Open Blinded End Point
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 6, 2019

First Posted

November 20, 2019

Study Start

February 10, 2019

Primary Completion

September 25, 2020

Study Completion

October 11, 2020

Last Updated

November 20, 2019

Record last verified: 2019-11

Locations